p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas

Molecular Cancer Therapeutics

Volumn 3, Issue 8, 2004, Pages 895-902

  Qin, Jian Zhong ^a   Stennett, Lawrence ^a   Bacon, Patricia ^a   Bodner, Barbara ^a   Hendrix, Mary J C ^b   Seftor, Richard E B ^b   Seftor, Elisabeth A ^b   Margaryan, Naira V ^b   Pollock, Pamela M ^c   Curtis, Amy ^c   Trent, Jeffrey M ^c   Bennett, Frank ^d   Miele, Lucio ^e   Nickoloff, Brian J ^a,f  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^d ISIS PHARMACEUTICALS   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BH3 PROTEIN; BIM PROTEIN; CISPLATIN; CYCLOHEXIMIDE; DOXORUBICIN; ETOPOSIDE; GAMMA SECRETASE INHIBITOR; GENE PRODUCT; NOTCH RECEPTOR; PROTEIN NOXA; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RECURRENCE; CANCER RESISTANCE; CELL CYCLE G2 PHASE; CELL DAMAGE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MELANOMA CELL; METASTASIS POTENTIAL; MITOCHONDRION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TREATMENT FAILURE;

ANNEXIN A5; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; G2 PHASE; HUMANS; IMMUNOBLOTTING; MELANOCYTES; MELANOMA; MEMBRANE PROTEINS; MITOCHONDRIA; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; OLIGONUCLEOTIDES, ANTISENSE; PHENOTYPE; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, NOTCH; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 4444303958     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002 CA Cancer J Clin 2002;52:23-47.
2. Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene 2003;22:3138-51.
3. Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 2003;3:559-70.
4. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 2001;409:207-11.
5. Chipuk JE, Kuwana T, Bouchier-Hayes L, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004;303:1010-4.
6. Nickoloff BJ, Osborne BA, Miele L. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene 2003;22:6598-608.
7. Hendrix MJ, Seftor RE, Seftor EA, Gruman LM, Lee LM, Nickoloff BJ, et al. Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination. Cancer Res 2002;62: 665-8.
8. Wolfe MS. Secretase targets for Alzheimer's disease: identification and therapeutic potential. J Med Chem 2001;44:2039-60.
9. Josien H. Recent advances in the development of γ-secretase inhibitors. Curr Opin Drug Discov Dev 2002;5:513-25.
10. Hartmann T, Bieger SC, Bruhl B, Tienari PJ, Ida N, Allsop D, et al. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides. Nat Med 1997;3:1016-20.
11. Hendrix MJ, Seftor EA, Seftor RE, Trevor KT. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol 1997;150:483-95.
12. Qin J, Chaturvedi V, Bonish B, Nickoloff BJ. Avoiding premature apoptosis of normal epidermal cells. Nat Med 2001;7:385-6.
13. Denning MF, Wang Y, Nickoloff BJ, Wrone-Smith T. Protein kinase Cδ is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes. J Biol Chem 1998;273: 29995-30002.
14. Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ, Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 1998;161:2833-40.
15. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001;292:727-30.
16. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000;288:1053-8.
17. Bouillet P, Cory S, Zhang LC, Strasser A, Adams JM. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell 2001;1:645-53.
18. Shibue T, Takeda K, Oda E, Tanaka H, Murasawa H, Takaoka A, et al. Integral role of Noxa in p53-mediated apoptotic response. Genes Dev 2003;17:2233-8.
19. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 2001;7:673-82.
20. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001;7:683-94.
21. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ, et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003;302:1036-8.
22. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999;399:483-7.
23. Chang EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX-and BAK-mediated mitochondrial apoptosis. Mol Cell 2001;8:705-11.
24. Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ. Development and maintenance of B and T lymphocytes requires anti-apoptotic MCL-1. Nature 2003;426:671-6.
25. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000;102:33-42.
26. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000;102:43-53.